Analyst Price Targets — AMGN
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| February 19, 2026 9:19 pm | — | Barclays | $185.00 | $375.50 | TheFly | Amgen initiated with an Equal Weight at Barclays |
| February 19, 2026 11:27 am | — | Wells Fargo | $375.00 | $379.73 | TheFly | Amgen price target raised to $375 from $325 at Wells Fargo |
| February 18, 2026 11:42 am | — | Piper Sandler | $432.00 | $373.36 | TheFly | Amgen price target raised to $432 from $381 at Piper Sandler |
| February 11, 2026 12:51 pm | — | Mizuho Securities | $295.00 | $364.65 | TheFly | Amgen price target raised to $295 from $280 at Mizuho |
| February 4, 2026 2:10 pm | — | RBC Capital | $360.00 | $357.29 | TheFly | Amgen price target raised to $360 from $335 at RBC Capital |
| February 4, 2026 1:27 pm | — | Morgan Stanley | $309.00 | $351.81 | TheFly | Amgen price target raised to $309 from $304 at Morgan Stanley |
| January 29, 2026 1:18 pm | — | Oppenheimer | $400.00 | $343.57 | TheFly | Amgen price target raised to $400 from $380 at Oppenheimer |
| January 26, 2026 1:37 pm | — | UBS | $390.00 | $348.99 | TheFly | Amgen price target raised to $390 from $380 at UBS |
| January 20, 2026 3:17 pm | Market Perform | Bernstein | $335.00 | $330.44 | TheFly | Amgen downgraded to Market Perform from Outperform at Bernstein |
| January 6, 2026 9:25 pm | — | UBS | $380.00 | $330.17 | TheFly | Amgen assumed at Buy from Neutral at UBS |
Latest News for AMGN
Amgen Inc. (AMGN) Presents at TD Cowen 46th Annual Health Care Conference Transcript
High-yield stocks are outperforming, with a clear rotation from growth to value driving strong returns for dividend-focused investors. Safe, high-yielding companies are still trading at discounts. These 3 are in the process of rerating, providing an appealing position to initiate a position.
111 Capital acquired a new position in shares of Amgen Inc. (NASDAQ: AMGN) during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor acquired 6,843 shares of the medical research company's stock, valued at approximately $1,931,000. A number of
The article presents a rigorously screened list of 10 top closed-end funds, or CEFs, for income investors, offering an average 9.7% yield and -10% NAV discount. Selections emphasize sector diversification, long-term outperformance, sustainable distributions, and attractive valuations, with a focus on both equity and credit-oriented CEFs. CEFs are generally characterized by higher volatility and deeper drawdowns than…
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
Senate Trading Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.